Article
Genetic variants in the mTOR pathway and breast cancer risk in African American women.
Carcinogenesis - 1 Jan 2016
Cheng Ting-Yuan David, Ambrosone Christine B, Hong Chi-Chen, Lunetta Kathryn L, Liu Song, Hu Qiang, Yao Song, Sucheston-Campbell Lara, Bandera Elisa V, Ruiz-Narváez Edward A, Haddad Stephen, Troester Melissa A, Haiman Christopher A, Bensen Jeannette T, Olshan Andrew F, Palmer Julie R, Rosenberg Lynn
Abstract excerpt
The phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (mTOR) pathway has been implicated in breast carcinogenesis. However, there has been no large-scale investigation of genetic variants in the mTOR pathway and breast cancer risk. We examined 28847 single-nucleotide polymorphisms (SNPs) in 61 mTOR pathway genes in the African American Breast Cancer Epidemiology and Risk consortium of 3663 cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
